Novel four drug combination proves safe for lung cancer treatment
Friday, November 14, 2008 - 14:42
in Health & Medicine
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Centre...
Read the whole article on Science Centric
More from Science Centric
Related
- Novel 4-drug combination proves safe for lung cancer treatmentThu, 13 Nov 2008, 10:30:54 EST
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- New treatment combination proves safe, effective for head and neck cancer patientsMon, 2 Jun 2008, 17:14:58 EDT
- Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patientsThu, 13 Nov 2008, 10:51:01 EST
- Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percentMon, 21 Sep 2009, 19:17:30 EDT